Transgenic Overexpression of Dystroglycan Does Not Inhibit Muscular Dystrophy in mdx Mice

American Journal of Pathology

Volumn 164, Issue 2, 2004, Pages 711-718

  Hoyte, Kwame ^a   Jayasinha, Vianney ^a   Xia, Bing ^a   Martin, Paul T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DYSTROGLYCAN; DYSTROPHIN; GLYCOPROTEIN; SARCOGLYCAN; UTROPHIN; CYTOSKELETON PROTEIN; DAG1 PROTEIN, HUMAN; MEMBRANE PROTEIN; UTRN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; GENE OVEREXPRESSION; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SKELETAL MUSCLE; TRANSGENIC MOUSE; ANIMAL; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SARCOLEMMA; UPREGULATION; WESTERN BLOTTING; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; BLOTTING, WESTERN; CREATINE KINASE; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; SARCOLEMMA; UP-REGULATION; UTROPHIN;

EID: 1542319861     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63158-6     Document Type: Article

References (35)

1. Blake DJ, Weir A, Newey SE, Davies KE: Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev, 2002, 82:291-329
2. Martin PT: Role of transcription factors in skeletal muscle and the potential for pharmacological manipulation. Curr Opin Pharmacol 2003, 3:300-308
3. Cox GA, Cole NM, Matsumura K, Phelps S, Hauchka SD, Campbell KP, Faulkner JA, Chamberlain JS: Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 1993, 364:725-729
4. Tinsley J, Deconinck N, Fisher R, Kahn D, Sphelps S, Gillis J-M, Davies K: Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 1998, 4:1441-1444
5. Nguyen HH, Jayasinha V, Xia B, Hoyte K, Martin PT: Overexpression of the cytotoxic T cell GaINAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc Natl Acad Sci USA 2002, 99:5616-5621
6. Wehling M, Spencer MJ, and Tidball JG: A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 2001, 155:123-131
7. Kronqvist P, Kawaguchi N, Albrechtsen R, Xu X, Schroder HD, Moghadaszadeh B, Nielsen FC, Frohlich C, Engvall E, Wewer UM: ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice. Am J Pathol 2002, 161:1535-1540
8. Spencer MJ, Mellgren RL: Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet 2002, 11:2645-2655
9. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL: Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 2002, 157:137-148
10. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ: Enhanced expression of the α7β1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol 2001, 152:1207-1218
11. Moll J, Barzaghi P, Lin S, Bezakova G, Lochmuller H, Engvall E, Muller U, Ruegg MA: An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature 2001, 413: 302-307
12. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LE, Ahima RS, Khurana TS: Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002, 420:418-421
13. Rybakova IN, Patel JR, Davies KE, Yurchenco PD, Ervasti JM: Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Cell Biol 2002, 13:1512-1521
14. Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, Campbell KP: Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 1991, 7:499-508
15. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP: Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 1992, 360:588-591
16. Galvagni F, Cantini M, Oliviero S: The utrophin gene is transcriptionally upregulated in regenerating muscle. J Biol Chem 2002, 277: 19106-19113
17. Martin PT: Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology 2003, 13:55R-65R
18. Smith PL, Lowe JB: Molecular cloning of a murine N-acetylgalactosamine transferase cDNA that determines expression of the T lymphocyte-specific CT oligosaccharide differentiation antigen. J Biol Chem 1994, 269:15162-15171
19. Martin PT, Scott LJC, Porter BE, Sanes JR: Distinct structures and functions of related pre- and postsynaptic carbohydrates at the mammalian neuromuscular junction. Mol Cell Neurosci 1999, 13: 105-118
20. Xia B, Hoyte K, Kammesheidt A, Deerinck T, Ellisman M, Martin PT: Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression. Dev Biol 2002, 242:58-73
21. Chung W, Campanelli JT: WW and EF hand domains of dystrophin-family proteins mediate dystroglycan binding. Mol Cell Biol Res Commun 1999, 2:162-171
22. Jayasinha V, Nguyen HH, Xia B, Kammesheidt A, Hoyte K, Martin PT: Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice. Neuromusc Disord 2003, 5:365-375
23. Herrmann R, Straub V, Blank M, Kutzick C, Franke N, Jacob E, Lenard H, Kroger S, Voit T: Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 2000, 9:2335-2340
24. de La Porte S, Morin S, Koenig J: Characteristics of skeletal muscle in mdx mutant mice. Int Rev Cytol 1999, 191:99-148
25. Ervasti JM, Campbell KP: A role for the dystrophin-glycoprotein complex as a transmembrane linker between actin and laminin. J Cell Biol 1993, 122:809-823
26. Patton BL, Miner JH, Chiu AY, Sanes JR: Localization, regulation, and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J. Cell Biol 139:1507-1521, 1997
27. Patton BL, Connolly AM, Martin PT, Cunningham JM, Mehta S, Pestronk A, Miner JH, Sanes JR: Distribution of ten laminin chains in dystrophic and regenerating muscles. Neuromusc Disord 1999, 9:423-433
28. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR: Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 1997, 90:729-738
29. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE: Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997, 90:717-727
30. Sanes JR, Lichtman JW: Development of the neuromuscular junction. Annu Rev Neurosci 1999, 22:389-442
31. Martin PT, Freeze HH: Glycobiology of neuromuscular disorders. Glycobiology 2003, 13:67R-75R
32. Jasmin BJ, Angus LM, Belanger G, Chakkalakal JV, Gramolini AO, Lunde JA, Stocksley MA, Thompson J: Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers: insights into a therapeutic strategy for Duchenne muscular dystrophy. J Physiol Paris 2002, 96:31-42
33. Courdier-Fruh I, Barman L, Briguet A, Meier T: Glucocorticoid-mediated regulation of utrophin levels. Neuromusc Disord 2002, 12:S95-S104
34. Greenberg DS, Sunada Y, Cambpell KP, Yaffe D, Nudel U: Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat Genet 1994, 8:340-344
35. Leibovitz S, Meshorer A, Fridman Y, Wieneke S, Jockusch H, Yaffe D, Nudel U: Exogenous Dp71 is a dominant negative competitor of dystrophin in skeletal muscle. Neuromusc Disord 2002, 12: 836-844